SEVERE HYPERTRIGLYCERIDEMIA
Clinical trials for SEVERE HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new SEVERE HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for SEVERE HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot cuts dangerous fat levels in blood, study shows
Disease control CompletedThis study tested a new medicine called olezarsen in 617 adults with severely high triglycerides, a type of blood fat that raises the risk of heart problems and pancreatitis. Participants received either the drug or a placebo as a shot under the skin. The main goal was to see if …
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 07:38 UTC
-
New injection shows promise for dangerous high fat levels
Disease control CompletedThis study tested an experimental drug called ARO-APOC3 in 229 adults with severely high triglycerides (a type of blood fat). Participants received two injections of the drug or a placebo. The main goal was to see if the drug safely lowers triglyceride levels after 24 weeks, with…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New injection shows promise for dangerous high fat levels in blood
Disease control CompletedThis study tested a new drug called DR10624 in 79 adults with severely high triglycerides, a type of blood fat that raises the risk of heart disease and pancreatitis. Participants received weekly injections of the drug or a placebo for 12 weeks. The main goal was to see if the dr…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New shot cuts dangerous fat levels in blood, study shows
Disease control CompletedThis study tested a drug called olezarsen in 446 people with very high triglycerides (a type of blood fat). Participants received either the drug or a placebo as a shot under the skin. The main goal was to see if olezarsen could lower triglyceride levels more than placebo. Result…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New drug shows promise for lowering dangerous fat levels in the blood
Disease control CompletedThis study tested an experimental drug called olezarsen in 154 adults with very high triglycerides (a type of blood fat) and either heart disease or a high risk for it. The goal was to see if the drug could safely lower triglyceride levels more than a placebo over 6 and 12 months…
Matched conditions: SEVERE HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 07, 2026 18:43 UTC